000			01121nam a22001457a 4500
999			_c525955 _d525955
008			240426b ||||| |||| 00| 0 eng d
100			_aAtal, Juan Pablo et al _951910
245			_a The economics of the public option: Evidence from local pharmaceutical markets
260			_aThe American Economic Review
300			_a114(3), Mar, 2024: p.615-644
520			_aWe study the effects of competition by state-owned firms, leveraging the decentralized entry of public pharmacies to local markets in Chile. Public pharmacies sell the same drugs at a third of private pharmacy prices, because of stronger upstream bargaining and market power in the private sector, but are of lower quality. Public pharmacies induced market segmentation and price increases in the private sector, which benefited the switchers to the public option but harmed the stayers. The countrywide entry of public pharmacies would reduce yearly consumer drug expenditure by 1.6 percent.- Reproduced https://www.aeaweb.org/articles?id=10.1257/aer.20211547
773			_aThe American Economic Review
906			_aECONOMICS
942			_cAR